Eagle to Acquire Arsia, Boosts Formulation Capabilities for Biologics, Biobetters
By
Eagle Pharmaceuticals, headquartered in Woodcliff Lake, New Jersey, has agreed to acquire Arsia Therapeutics, a Cambridge, Massachusetts-headquartered early-stage biotechnology firm with proprietary viscosity-reducing technology and formulation expertise, in a deal…